Earnings Preview For G1 Therapeutics
Portfolio Pulse from Benzinga Insights
G1 Therapeutics (NASDAQ:GTHX) is set to release its quarterly earnings report on November 1, 2023. Analysts estimate an earnings per share (EPS) of $-0.33. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. However, the stock has been on a downward trend, with shares down 79.9% over the last 52-week period.
October 31, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
G1 Therapeutics is expected to report an EPS of $-0.33. Despite past EPS beats, the stock has been on a downward trend, with shares down 79.9% over the last 52-week period.
The company's earnings report is a key event that could impact its stock price. Despite past EPS beats, the stock has been on a downward trend, which indicates bearish sentiment among investors. This could potentially lead to further declines in the stock price following the earnings announcement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100